Publikationen der ALS-Forschungsgruppe an der Charité ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scaleMaier A, Boentert M, Reilich P, Mehr ALSFRS-R-SE: an adapted, annotated, and self-explanatory version of the revised amyotrophic lateral sclerosis functional rating scale Neurofilament light chain response during therapy with antisense oligonucleotide Tofersen in SOD1-related ALS – treatment experience in clinical practiceMeyer T, Schumann P, Weydt P, Mehr Neurofilament light chain response during therapy with antisense oligonucleotide Tofersen in SOD1-related ALS – treatment experience in clinical practice Performance of serum neurofilament light chain in a wide spectrum of clinical courses of amyotrophic lateral sclerosis – a cross-sectional multicenter studyMeyer T, Salkic E, Grehl T, Mehr Performance of serum neurofilament light chain in a wide spectrum of clinical courses of amyotrophic lateral sclerosis – a cross-sectional multicenter study Der Einsatz von Patient-reported Outcome Measures (PROM) und die Perspektive digitaler Biomarker bei der Amyotrophen LateralskleroseMaier A, Münch C, Meyer T. Mehr Der Einsatz von Patient-reported Outcome Measures (PROM) und die Perspektive digitaler Biomarker bei der Amyotrophen Lateralsklerose Acceptance of Enhanced Robotic Assistance Systems in People With Amyotrophic Lateral Sclerosis-Associated Motor Impairment: Observational Online StudyMaier A, Eicher C, Kiselev J, Mehr Acceptance of Enhanced Robotic Assistance Systems in People With Amyotrophic Lateral Sclerosis-Associated Motor Impairment: Observational Online Study Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational studyMeyer T, Spittel S, Grehl T, Mehr Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational study 1 2 3 … 6 Weiter » Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral SclerosisLudolph AC, Dorst J, Dreyhaupt J, Mehr Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis Prognostic factors in ALS: a comparison between Germany and ChinaDorst J, Chen L, Rosenbohm A, Mehr Prognostic factors in ALS: a comparison between Germany and China GABA B receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosisSchumacher H, Meyer T, Prüss H. Mehr GABA B receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trialLudolph AC, Schuster J, Dorst J, Mehr Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial Comprehensive analysis of the mutation spectrum in 301 German ALS familiesMüller K, Brenner D, Weydt P, Mehr Comprehensive analysis of the mutation spectrum in 301 German ALS families Therapeutic decision in ALS patients: cross-cultural differences and clinical implicationsAndersen PM, Kuzma-Kozakiewicz M, Keller J, Mehr Therapeutic decision in ALS patients: cross-cultural differences and clinical implications 1 2 3 … 8 Weiter »
